THERAVANCE INC - COMMON STOCK (THRX)

CUSIP: 88338T104

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / COMMON STOCK
Total 13F shares
87,670,644
Share change
-10,940,588
Total reported value
$924,053,166
Put/Call ratio
27%
Price per share
$10.54
Number of holders
92
Value change
-$65,867,854
Number of buys
42
Number of sells
64

Quarterly Holders Quick Answers

What is CUSIP 88338T104?
CUSIP 88338T104 identifies THRX - THERAVANCE INC - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAVANCE INC - COMMON STOCK (THRX) as of Q4 2015

As of 31 Dec 2015, THERAVANCE INC - COMMON STOCK (THRX) was held by 92 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 87,670,644 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, FMR LLC, IRIDIAN ASSET MANAGEMENT LLC/CT, VANGUARD GROUP INC, BlackRock Fund Advisors, Empyrean Capital Partners, LP, CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD, Partner Fund Management, L.P., BlackRock Institutional Trust Company, N.A., and BANK OF AMERICA CORP /DE/. This page lists 92 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.